The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism.
about
The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
The prognostic impact of serum ...... r and the SRD5A2 polymorphism.
@en
The prognostic impact of serum ...... r and the SRD5A2 polymorphism.
@nl
type
label
The prognostic impact of serum ...... r and the SRD5A2 polymorphism.
@en
The prognostic impact of serum ...... r and the SRD5A2 polymorphism.
@nl
prefLabel
The prognostic impact of serum ...... r and the SRD5A2 polymorphism.
@en
The prognostic impact of serum ...... r and the SRD5A2 polymorphism.
@nl
P2093
P2860
P356
P1476
The prognostic impact of serum ...... r and the SRD5A2 polymorphism.
@en
P2093
A Takeuchi
A Yokomizo
E Kashiwagi
J Inokuchi
K Kiyoshima
K Tatsugami
N Fujimoto
P2860
P2888
P304
P356
10.1038/PCAN.2016.2
P577
2016-02-09T00:00:00Z
P6179
1036890576